H-E-B to distribute COVID-19 vaccines in Houston stores

Calling the Shots

H-E-B plans to offer COVID-19 vaccines once they're available. Photo courtesy of BCM

As a pair of COVID-19 vaccines await emergency-use approval from the U.S. Food and Drug Administration, Texas' largest grocer is prepping for the vaccines' unprecedented rollout.

San Antonio-based H-E-B announced its pharmacies will administer the COVID-19 vaccine to Texans once it's available to the general public.

"At H-E-B, the health and safety of Texans is our top priority," the company noted in a release posted December 3. "As a trusted source for all routine childhood and adult immunizations, H-E-B pharmacies will partner with the federal and state government to administer the COVID-19 vaccine when it becomes available to the general public, following the CDC distribution schedule."

Though it's unclear when H-E-B will receive the vaccine doses and which company's vaccine —Moderna, the Pfizer/BioNTech, or otherwise — will be available through the grocer, health-focused organizations and businesses like H-E-B are preparing for the massive distribution, which could begin as soon as 24 hours after the FDA gives its approval.

The goal of Operation Warp Speed, the federal government's plan to help develop, make, and distribute millions of COVID-19 vaccine doses to Americans, is "to deliver safe vaccines that work, with the first supply becoming available before the end of 2020," according to the Centers for Disease Control and Prevention.

The CDC also notes once a vaccine is approved and released, there may not be enough doses available for all U.S. adults, though supplies will increase over time and "all adults should be able to get vaccinated later in 2021."

The CDC further states that vaccine doses purchased with taxpayer money will be distributed to Americans for free. However, vaccine providers can charge an administration fee for providing the shot.

It's unclear how many doses each store will receive and whether the company plans to distribute the vaccine through its pharmacy drive-thrus, at onsite pop-up medical tents, or solely from its in-store pharmacies.

"We do have all H-E-B pharmacies registered and ready to administer the vaccine," says Leslie Sweet, H-E-B's director of public affairs in the Central Texas region. "We will follow the prescribed allocation schedule as prescribed by [the Department of State Health Services]. We do not yet have a specific date or allocation number to share."

H-E-B pharmacies throughout the state already have some safety measures in place because of COVID-19 concerns, including allowing customers to prepay for prescriptions on the phone prior to picking them up or have their prescriptions delivered for free, and offering no-contact pickup and delivery of prescriptions through its pharmacy drive-thrus.

Additionally, H-E-B says it is continuing to take steps to protect its customers and employees during the pandemic.

"We're going above and beyond our already stringent sanitation standards, cleaning and disinfecting pharmacy counters, waiting areas, and drive-thru surfaces at a higher frequency," the grocer notes in its recent release. "Our pharmacy partners are practicing proper hand-washing throughout the day, and disinfecting and wiping down commonly used surfaces. We've also installed acrylic barriers and provided masks and gloves for all pharmacy partners. … As always, your health and safety is of the utmost importance to us. Together, we can slow the spread."

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

TMC lands $3M grant to launch cancer device accelerator

cancer funding

A new business accelerator at Houston’s Texas Medical Center has received a nearly $3 million grant from the Cancer Prevention and Research Institute of Texas.

The CPRIT grant, awarded to the Texas Medical Center Foundation, will help launch the Accelerator for Cancer Medical Devices. The accelerator will support emerging innovators in developing prototypes for cancer-related medical devices and advancing them from prototype to clinical trials.

“The translation of new cancer-focused precision medical devices, often the width of a human hair, creates the opportunity to develop novel treatments for cancer patients,” the accelerator posted on the CPRIT website.

Scientist, consultant, and entrepreneur Jason Sakamoto, associate director of the TMC Center for Device Innovation, will oversee the accelerator. TMC officials say the accelerator builds on the success of TMC Innovation’s Accelerator for Cancer Therapeutics.

Each participant in the Accelerator for Cancer Medical Devices program will graduate with a device prototype, a business plan, and a “solid foundation” in preclinical and clinical strategies, TMC says. Participants will benefit from “robust support” provided by the TMC ecosystem, according to the medical center, and “will foster innovation into impactful and life-changing cancer patient solutions in Texas and beyond.”

In all, CPRIT recently awarded $27 million in grants for cancer research. That includes $18 million to attract top cancer researchers to Texas. Houston institutions received $4 million for recruitment:

  • $2 million to the University of Texas MD Anderson Cancer Center to recruit Rodrigo Romero from Memorial Sloan Kettering Cancer Center in New York City
  • $2 million to MD Anderson to recruit Eric Gardner from Weill Cornell Medicine in New York City

A $1 million grant also went to Baylor College of Medicine researcher Dr. Akiva Diamond. He is an assistant professor at the medical college and is affiliated with Baylor’s Dan L. Duncan Comprehensive Cancer Center.

Musk’s SpaceX spends $17B to acquire spectrum licenses from EchoStar

SpaceX Update

Elon Musk’s SpaceX has reached a deal worth about $17 billion with EchoStar for spectrum licenses that it will use to beef up its Starlink satellite network.

The deal for EchoStar’s AWS-4 and H-block spectrum licenses includes up to $8.5 billion in cash and up to $8.5 billion in SpaceX stock. SpaceX will make approximately $2 billion in cash interest payments on EchoStar debt through November 2027.

SpaceX and EchoStar will enter into a long-term commercial agreement which will allow EchoStar’s Boost Mobile subscribers to access SpaceX’s next generation Starlink Direct to Cell service.

Shares of EchoStar surged 19% before the market opened Monday.

Last month AT&T said that it will spend $23 billion to acquire wireless spectrum licenses from EchoStar, a significant expansion of its low- and mid-band coverage networks.

EchoStar said that it anticipates that the AT&T deal and the SpaceX transaction will resolve recent inquiries from the Federal Communications Commission about the rollout of 5G technology in the U.S. The FCC had been calling for hearings on whether Echostar was properly using the spectrum that it is now selling, and its efforts to make 5G more available to communities.

EchoStar said Monday that it will use the proceeds from the sale partly to pay down debt. Current operations of Dish TV, Sling and Hughes will not be impacted, the company said.

Houston students develop cost-effective glove to treat Parkinson's symptoms

smart glove

Two Rice undergraduate engineering students have developed a non-invasive vibrotactile glove that aims to alleviate the symptoms of Parkinson’s disease through therapeutic vibrations.

Emmie Casey and Tomi Kuye developed the project with support from the Oshman Engineering Design Kitchen (OEDK) and guidance from its director, Maria Oden, and Rice lecturer Heather Bisesti, according to a news release from the university.

The team based the design on research from the Peter Tass Lab at Stanford University, which explored how randomized vibratory stimuli delivered to the fingertips could help rewire misfiring neurons in the brain—a key component of Parkinson’s disease.

Clinical trials from Stanford showed that coordinated reset stimulation from the vibrations helped patients regain motor control and reduced abnormal brain activity. The effects lasted even after users removed the vibrotactile gloves.

Casey and Kuye set out to replicate the breakthrough at a lower cost. Their prototype replaced the expensive motors used in previous designs with motors found in smartphones that create similar tiny vibrations. They then embedded the motors into each fingertip of a wireless glove.

“We wanted to take this breakthrough and make it accessible to people who would never be able to afford an expensive medical device,” Casey said in the release. “We set out to design a glove that delivers the same therapeutic vibrations but at a fraction of the cost.”

Rice’s design also targets the root of the neurological disruption and attempts to retrain the brain. An early prototype was given to a family friend who had an early onset of the disease. According to anecdotal data from Rice, after six months of regularly using the gloves, the user was able to walk unaided.

“We’re not claiming it’s a cure,” Kuye said in the release. “But if it can give people just a little more control, a little more freedom, that’s life-changing.”

Casey and Kuye are working to develop a commercial version of the glove priced at $250. They are taking preorders and hope to release 500 pairs of gloves this fall. They've also published an open-source instruction manual online for others who want to try to build their own glove at home. They have also formed a nonprofit and plan to use a sliding scale price model to help users manage the cost.

“This project exemplifies what we strive for at the OEDK — empowering students to translate cutting-edge research into real-world solutions,” Oden added in the release. “Emmie and Tomi have shown extraordinary initiative and empathy in developing a device that could bring meaningful relief to people living with Parkinson’s, no matter their resources.”

View All Listings